Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors
Maher Albitar, Ahmad Charifa, Sally Agersborg, Omar Butt, Adam Albitar, Na Tosha N Gatson, Andre Goy, Santosh Kesari · 2026
Read Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors by Maher Albitar, Ahmad Charifa, Sally Agersborg, Omar Butt, Adam Albitar, Na Tosha N Gatson, Andre Goy, Santosh Kesari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13597192.txt.
Description
Maher Albitar and co-authors test whether fluid from around the brain and spine can reveal and track tumors of the central nervous system. Spinal fluid is easier to reach than brain tissue, and tumor cells shed DNA and RNA into it. Their 2026 study reviews real-world test results from 1,391 spinal fluid samples sent in for clinical testing.
A gene panel read the free DNA and RNA in each sample. About 78 percent of samples carried mutations matching a primary or spread tumor, while about 17 percent were fully clear. RNA levels were often very low, yet the tests still caught gene fusions in 68 cases. In five cases they found traces of engineered immune cells that blood tests had missed. The authors call the combined test reliable and often practice-changing.
Catalog record
| CREATOR | Maher Albitar, Ahmad Charifa, Sally Agersborg, Omar Butt, Adam Albitar, Na Tosha N Gatson, Andre Goy, Santosh Kesari |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |